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Whey bioremediationβ-Galactosidases (EC 3.2.1.23) constitute a large family of proteins that are known to catalyze both hydrolytic
and transgalactosylation reactions. The hydrolytic activity has been applied in the food industry for decades
for reducing the lactose content in milk, while the transgalactosylation activity has been used to synthesize
galacto-oligosaccharides and galactose containing chemicals in recent years. The main focus of this review is
on the expression and production of Aspergillus niger, Kluyveromyces lactis and bacterial β-galactosidases in
different microbial hosts. Furthermore, emphasis is given on the reported applications of the recombinant
enzymes. Current developments on novel β-galactosidases, derived from newly identiﬁed microbial sources
or by protein engineering means, together with the use of efﬁcient recombinant microbial production systems
are converting this enzyme into a relevant synthetic tool. Thermostable β-galactosidases (cold-adapted or
thermophilic) in addition to the growingmarket for functional foods will likely redouble its industrial interest.: +351 253 678 986.
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1.1. The β-galactosidase enzyme
β-galactosidase (commonly also known as lactase) is an enzyme
(EC 3.2.1.23) that catalyzes the hydrolysis of terminal non-reducingβ-D-galactose residues in β-D-galactosides (http://expasy.org/enzyme/
3.2.1.23; Gasteiger et al., 2003). Conventionally, its main application has
been in thehydrolysis of lactose inmilk or derived products, particularly
cheesewhey.More recently, β-galactosidases with transgalactosylation
activities (i.e. which can oligomerise galactosides) have been exten-
sively exploited for the production of functional galactosylatedproducts
(Fig. 1).
Many organisms naturally synthesize β-galactosidase, including
microorganisms, plant and animal cells (Husain, 2010; Panesar et al.,
2006). Traditionally, the β-galactosidases most widely used in industry
Fig. 1. Biotechnological applications of β-galactosidases: hydrolysis of lactose in milk and cheese whey and synthesis of GOS or other lactose/galactose derivatives by
transgalactosylation reactions. The gray boxes show examples of microbial enzyme sources for each application. (c)Cold-active enzymes; (t)thermophilic enzymes.
601C. Oliveira et al. / Biotechnology Advances 29 (2011) 600–609were obtained from Aspergillus spp. and Kluyveromyces spp. (Husain,
2010; Panesar et al., 2006; Siso, 1996; Zadow, 1984), because these
could be readily obtainedwith acceptable productivities and yields from
cultivations of these microorganisms. Additionally, products obtained
from these organisms are generally recognized as safe (GRAS status) for
human consumption, which is critical for food related applications
(Kosseva et al., 2009; Panesar et al., 2006; Siso, 1996). In Aspergillus spp.
β-galactosidase is secreted to the extracellular medium. These fungal
enzymes have a pH optimum in the acidic range (2.5–5.4) and a high
temperature optimum that allows their use at temperatures up to 50 °C
(Panesar et al., 2006; Zadow, 1984). Their main application is in the
hydrolysis of acid whey, which derives from the production of fresh or
soft cheeses (YangandSilva, 1995). Conversely, inKluyveromyces spp. the
β-galactosidase is intracellular; lactose is ﬁrst transported to the interior
of the yeast cell by a permease and then hydrolyzed intracellularly to
glucose and galactose, which follow the glycolytic pathway or the Leloir
pathway, respectively (Domingues et al., 2010). The yeast enzyme has a
near neutral optimum pH (6.0–7.0) and therefore has a broader range of
applications, particularly in the hydrolysis of milk and sweet whey
(derived from hard cheese manufacturing) (Panesar et al., 2006; Yang
and Silva, 1995; Zadow, 1984). Because of its intracellular nature, the
enzyme needs to be extracted from the yeast cells by disrupting or
permeabilizing the cells using chemical and/or mechanical treatments
(Panesar et al., 2006).
Panesar et al. (2006) compiled a list of β-galactosidase commercial
preparations. Yeast sources areKluyveromyces lactis andKluyveromyces
marxianus (species that now includes former species Kluyveromyces
fragilis and Saccharomyces fragilis as well as its anamorph Candida
pseudotropicalis; Lachance, 1998), while fungal sources include
Aspergillus niger and Aspergillus oryzae. The β-galactosidase from
Escherichia coli is the most extensively studied but its industrial use is
hampered by the fact that it is not considered safe for food applications.
Nevertheless, it is commercially available for analytical purposes
(Panesar et al., 2006; Siso, 1996). Finally, a preparation obtained from
Bacillus sp. is also commercialized (Panesar et al., 2006).Lactic acid bacteria (include a diverse group of lactococci,
streptococci and lactobacilli) and biﬁdobacterium, which are recog-
nized as safe organisms, have been regarded as good sources of
β-galactosidases, especially for functional food applications (Husain,
2010). More recently, there has been growing interest in a
considerable number of β-galactosidases from other sources that
present diverse properties of biotechnological interest (Panesar et al.,
2006). Particular attention has been rewarded to thermotolerant or
cold-active enzymes from yeast and bacterial sources (Husain, 2010;
Panesar et al., 2006; Park and Oh, 2010b). The X-ray crystal structures
of several microbial β-galactosidases have been unraveled, although
none of the enzymes with solved structures is known to be used in
food processing (Gosling et al., 2010).
Nowadays, recombinant DNA technology can be used to express and
optimize the production of interesting β-galactosidases from the most
diverse sources in microbial hosts that are recognized for their highly
efﬁcient heterologous protein production. This possibility greatly
expands the range of potential applications for β-galactosidases and
their economically effective utilization in industrial processes. Modern
molecular biology tools combined with bioprocess engineering strate-
gies can be used to optimize protein production, resulting in technically
and economically effective enzyme production systems. Besides the
wide-ranging properties offered by natural sources, new features – such
as reduced product inhibition (Park and Oh, 2010b), higher product
yields (Gosling et al., 2010) or secretion signals (Becerra et al., 2001b) –
maybe built into speciﬁcβ-galactosidases using state-of-the-art protein
engineering tools.
1.2. Applications of β-galactosidase
Lactose is a disaccharide formed by glucose and galactose that is
found inmilk. In humans, lactose intolerance or lactosemalabsorption is
a common problem. In fact, it is estimated that over 70% of the world's
adult population have problems in digesting lactose (Adam et al., 2004;
Husain, 2010; Lifran et al., 2000), resulting from absent or reduced
602 C. Oliveira et al. / Biotechnology Advances 29 (2011) 600–609β-galactosidase activity in the small intestine. Indigested lactose
therefore passes into the large intestine where it is fermented by
colonic microﬂora causing symptoms such as abdominal pain, gas,
nausea and diarrhea (Adam et al., 2004; Husain, 2010). The extent of
these symptoms is variable and indeed most individuals can tolerate a
moderate amount of lactose in their diet (Lifran et al., 2000).
Nevertheless, there is a considerable market for lactose-free milk and
dairy products, which can be obtained by enzymatic hydrolysis using β-
galactosidases.
The solubility and sweetness of lactose is low compared to other
sugars, including glucose, galactose, fructose and sucrose (Gänzle et al.,
2008; Zadow, 1984). Therefore, lactose hydrolysis diminishes precip-
itation problems and enhances the sweetening power, thus expanding
the food applications of lactose solutions, for instance in the confec-
tionary and ice-cream industries replacing sucrose or starch syrups
(Siso, 1996; Zadow, 1984).
Besides milk, the main source of lactose is cheese whey, which is a
primary by-product of cheesemanufacturing. About 9 L of whey stream
are generated during the production of 1 kg of cheese, amounting to
over 160 million t of whey produced worldwide each year (Guimarães
et al., 2010). Whey's organic load is high (biochemical oxygen demand
of 30–50 g/L and chemical oxygen demand of 60–80 g/L), mainly
because of the lactose content, which togetherwith the high volumes to
which it is generated makes cheese whey a quite concerning
environmental issue, and solutions for its valorization are strongly
required (Guimarães et al., 2010). In this regard, lactose hydrolysis by
β-galactosidases again plays an important part by broadening whey's
applications. Particularly, whey fermentations can be expanded beyond
the somewhat limited capacities of lactose-consumingmicroorganisms,
to the use of lactose-hydrolyzedwhey as feedstock for the production of
added-value molecules or bulk commodities by lactose-negative
microbes. For instance, Saccharomyces cerevisiae wild strains (lactose-
negative) can be used to produce ethanol from hydrolyzed whey,
although catabolite repression-resistant mutants must be applied in
order to avoid glucose–galactosediauxy (Bailey et al., 1982; Terrell et al.,
1984). In the case of low-price bulk products, like ethanol, the cost of
β-galactosidase for hydrolysis is often the bottleneck limiting the
economical viability of the fermentation process.
Apart from lactose hydrolysis, β-galactosidases with transgalacto-
sylation activities are highly attractive for theproductionof added-value
lactose derivatives (Fig. 1). In particular, galacto-oligosaccharides (GOS)
are increasingly ﬁnding application in functional foods, namely as low-
calorie sweeteners in fermented milk products, confectioneries, breads
and beverages. The use of β-galactosidades for the production of GOS
has been most recently reviewed (Gosling et al., 2010; Park and Oh,
2010b).
There are two main options for the industrial application of
β-galactosidases: the “free enzyme” route using β-galactosidase in
solution or the use of immobilized enzyme bioreactors (Gänzle et al.,
2008). The free enzyme approach is technically simpler but the soluble
enzyme can hardly be reused,which represents amain drawback taking
into account the high costs of enzyme preparations. Nevertheless,
membrane technology, mostly based in ultraﬁltration membranes that
are not permeated by β-galactosidase, has been explored for recovering
and reusing the soluble enzyme (Gosling et al., 2010; Richmond et al.,
1981). Immobilization technology although technically more challeng-
ing provides enzyme recycling and the possibility of continuous
operation and may in some cases result in enhanced enzyme stability.
The methods for β-galactosidase immobilization as well as their
applications and the diverse bioreactor systems proposed for its use
have been recently reviewed (Husain, 2010; Kosseva et al., 2009;
Panesar et al., 2006). The utilization of whole cells provides an
alternative to circumvent the technical and economical efforts associ-
ated with enzyme extraction and isolation/puriﬁcation. The major
drawback is the poor permeability of cell membranes to lactose,
although the permeability of microbial cells can be increased bytreatmentwith chemical agents, such asdetergents or solvents (Panesar
et al., 2006).
2. Recombinant microbial systems for β-galactosidase production
2.1. Recombinant expression of non-bacterial β-galactosidases
This section focuses on the heterologous expression and production
of the β-galactosidases most used in the food industry, that is from the
ﬁlamentous fungi A. niger and from the yeast K. lactis in recombinant
yeast hosts (summarized in Table 1).
The deﬁnition of the β-galactosidase enzymatic activity unit (U) is
not equivalent in the reports concerning β-galactosidase from K. lactis
and fromA. niger. Hereafter, 1 U is deﬁned as the amount of enzyme that
hydrolyses 1 nmol of p-nitrophenyl-β-D-galactopyranoside (pNPG) or
o-nitrophenyl-β-D-galactopyranoside (oNPG) per min, and for consis-
tency the reported values for K. lactis β-galactosidasewere converted to
this enzymatic unit.
2.1.1. Heterologous production of A. niger β-galactosidase
Theﬁlamentous fungiA. nigerhas the ability to secreteβ-galactosidase
into the extracellular medium, which obviously facilitates the recovery
of the enzyme. This β-galactosidase is only suitable for the hydrolysis of
acidwheybecause its activity atpHvalueshigher thanoptimum(around
3.5) is quite diminished. Aiming this application, and to improve its
availability, A. niger β-galactosidase was cloned and produced in
recombinant S. cerevisiae strains.
A yeast multicopy expression vector carrying the cDNA for A. niger
secretory β-galactosidase under the control of ADH1 promoter and
terminator (lacA cassette) was constructed (plasmid pVK1.1) (Kumar
et al., 1992). This vector was used to engineer different recombinant S.
cerevisiae strains with the capacity to produce and secrete A. niger
β-galactosidase (Domingues et al., 2000a; Domingues et al., 2002;
Kumar et al., 1992; Oliveira et al., 2007; Ramakrishnan and Hartley,
1993). However, in the initial works, recombinants demonstrated low
growth rates on lactose (Kumar et al., 1992) or, despite rapid growth
and good fermentation characteristics under aerobic conditions,
showed low plasmid stability (10%) (Ramakrishnan and Hartley,
1993). Although recombinant β-galactosidase has been detected in
the culture medium as desired, its activity level was unsatisfactory
(Ramakrishnan and Hartley, 1993; Table 1). In our research group,
ﬂocculating recombinant yeasts secreting high levels of A. niger β-
galactosidase have been obtained (Domingues et al., 2000a; Domingues
et al., 2002; Oliveira et al., 2007). The advantage of using ﬂocculating
yeast cells is that it allows for continuous recombinant protein
production in high-cell-density systems. Due to their sedimentation
characteristics, increasing biomass concentration is attained inside the
bioreactor, leading to high recombinant protein productivities and
minimizing the risk of contamination (Domingues et al., 2000b). In
addition, the recovery of cells from media is facilitated, reducing the
downstream processing costs (Domingues et al., 1999). The capacity of
ﬂocculating yeast cells to secrete recombinant β-galactosidase was for
the ﬁrst time demonstrated using a brewer's yeast strain, transformed
with a recombinant vector containing the lacA cassette frompVK1.1 and
a copper resistance selection marker (CUP1 gene) (Domingues et al.,
2000a; Table 1). However, the ﬂocculating yeast strain S. cerevisiae
NCYC869-A3, transformed with the pVK1.1 vector, was able to produce
20 times more β-galactosidase activity in identical medium containing
less lactose (Domingues et al., 2002; Table 1). Therefore, optimization of
the large-scale production of A. niger recombinant β-galactosidase was
conducted with this recombinant yeast strain. The production of
recombinant β-galactosidase in a 2-L bioreactor with controlled
agitation, aeration, pH and temperature was carried out varying the
lactose and yeast extract concentrations in semi-synthetic medium
(SSlactose) (Domingues et al., 2002; Domingues et al., 2004). The
recombinant β-galactosidase activity increased linearly with increasing
Table 1
Heterologous production of Aspergillus niger and Kluyveromyces lactis β-galactosidases in yeast hosts.
Source of
the enzyme
Expression host/plasmid Media and culture conditions Extracellular recombinant β-galactosidase activity References
A. niger Mauri distiller's yeast/pVK1.1 Modiﬁed Dw medium+10% lactose
(2-L bioreactor)
10 U/mL Ramakrishnan and
Hartley, 1993
Brewer's yeast W204-FLO1L/
pET13.1+ lacA cassette (pLD1)
SSlactose 2% (shake ﬂasks) 17 U/mL Domingues et al.,
2000a
S. cerevisiae NCYC869-A3/pVK1.1 SSlactose 1%⁎ 350 U/mL Domingues et al.,
2002SSlactose 5%⁎⁎ 2000 U/mL
SSlactose 10%⁎⁎ 5096 U/mL
Cheese whey permeate 5% lactose⁎⁎
(⁎shake ﬂasks,⁎⁎2-L bioreactor)
2635 U/mL
SSlactose 15%+1.5% YE (10-L bioreactor) 7350 U/mL Domingues et al.,
2004
SSlactose 5% (6-L airlift bioreactor) Maximum: 3250 U/mL (D=0.4 h−1) Domingues et al.,
2005
S. cerevisiae NCYC869/pδ-neo+ lacA
cassette
SSlactose 5% (6-L airlift bioreactor) Maximum: 2754 U/mL (D=0.1 h−1) Oliveira et al.,
2007
K. lactis S. cerevisiae LD1/YEplac118-LAC4 YPD 2% glucose (shake ﬂasks) 17,000 U/mL Becerra et al., 1997
S. cerevisiae LHDP1/YEplac118-LAC4 40,000 U/mL
Six S. cerevisiae super-secreting
mutants
YPD 2% glucose Highest secretion for CGY158/YEplac181-
LAC4: 1700 U/mL in YPD
Becerra et al.,
2001a
Plasmids: pSPGK1-LAC4; YEplac181-LAC4
YPL 4 or 6% lactose (all shake ﬂasks)
K. lactis MW 190-9B/pSPGK1-LAC4 YPD 0.5% glucose K. lactis MW 190-9B/pSPGK1-LAC4:
-batch bioreactor, cheese whey permeate+
1% YE: up to 25,000 U/mL
-continuous bioreactor, YPL+0.1%
glucose: 150,000 U/mL
S. cerevisiae BJ3505/YEpFLAG1-LACA:
-optimization in shake-ﬂaks, YPHSM:
20,440 U/mL
Becerra et al.,
2001bYPL 4% lactose
YPHSM
S. cerevisiae BJ3505/YEpFLAG1-LACA
Cheese whey permeate 5% lactose+1% YE
(shake ﬂasks and 2-L bioreactor)
S. cerevisiae BJ3505/YEpFLAG1-LAC4 YPL 4 or 6% lactose YPL 4% lactose: up to 2000 U/mL Becerra et al., 2002
Cheese whey permeate+1% YE
(all shake ﬂasks)
YPL 6% lactose: up to 1500 U/mL
Optimization in cheese whey permeate+1%
YE: 8440 U/mL
S. cerevisiae LD1/YEplac181-LAC4 YPD 2% glucose
YPL 4 or 6% lactose
Cheese whey permeate 5% lactose
(all shake ﬂasks)
Higher yields for S. cerevisiae
LHDP1/YEplac181-LAC4: up to 500 U/mL
Becerra et al., 2004
S. cerevisiae LHDP1/YEplac181-LAC4
K. lactis and
A. niger
K. lactis MW 190-9B/pSPGK1-LAC4;
pSPGK1-LAC4-LACA
Culture medium is not described
(shake ﬂasks)
K. lactis/pSPGK1-LACA: up to 100 U/mL Rodríguez et al.,
2006K. lactis/pSPGK1-LAC4-LACA: up to 100–200 U/mL
603C. Oliveira et al. / Biotechnology Advances 29 (2011) 600–609lactose concentrations (between 0.5 and 15% (w/v)), as well as with
increasing yeast extract concentrations (between 0.2 and 1.5% (w/v)). It
is worth noting that the recombinant β-galactosidase activity produced
in medium containing 10% (w/v) lactose was comparable to that
obtained from A. niger but presented higher purity (Domingues et al.,
2002). In the same work, cheese whey permeate was successfully used
for recombinant β-galactosidase production, with rapid and complete
lactose metabolization (less than 40 h). Thus, this recombinant system
allows for the bioremediation of cheese whey and β-galactosidase
production simultaneously. Using optimized operation and culture
conditions a 21-fold increase in β-galactosidase production was
attained in a 10-L bioreactor, comparing with the previous fermenta-
tions conducted in Erlenmeyer ﬂasks (Domingues et al., 2004; Table 1).
The percentage of β-galactosidase secreting cells at the end of
fermentations was greater than 70%. The continuous production of
recombinant β-galactosidase was conducted in a high-cell-density 6-L
airlift bioreactor (Domingues et al., 2005; Table 1). As occurred in batch
fermentations, rapid and complete lactose consumption was observed
with the simultaneous production of ethanol at concentrations close to
the maximal theoretical values (25 g/L). The higher β-galactosidase
productivity (6.2×105 U/L/h) was obtained when operating at a
dilution rate of 0.24 h−1. This system allowed an 11-fold increase in
β-galactosidase productivitywhen compared to the batch system, using
the same medium with the same lactose concentration. However, at
higher dilution rates plasmid stabilitywas lowand, consequently, theβ-
galactosidase productivity decreased. To overcome this limitation, the
lacA expression cassette was integrated in the δ-sequences of thegenome of the ﬂocculating yeast strain S. cerevisiae NCYC869 (wild-
type) (Oliveira et al., 2007). The use of the δ-system together with G418
(geneticin) antibiotic selection resulted in ﬂocculating S. cerevisae
strains producing extracellular recombinant β-galactosidase at levels
comparable to themulticopy plasmid system inﬂask cultures.Under the
same airlift bioreactor operating conditions, the best integrant strain
obtained (carrying approximately eight lacA gene copies) had similarβ-
galactosidase production to the strain carrying the pVK1.1 vector but
was much more stable (95% and 40% of plasmid stability, respectively)
(Oliveira et al., 2007; Table 1). Therefore, the integrant strain presents
important advantages over the previously constructed strains for
continuous A. niger β-galactosidase production.2.1.2. Heterologous production of K. lactis β-galactosidase
The K. lactis β-galactosidase (encoded by the LAC4 gene) has a high
biotechnological interest in the food industry and in cheese whey
reutilization. The advantage of K. lactis over A. niger is that the yeast
produces higher quantity of enzymatic units. However, due to its
intracellular nature, the industrial production and application of K. lactis
β-galactosidase is limited by the costs associatedwith its extraction and
downstreamprocessing. Therefore, two strategies have been adopted to
secrete K. lactis β-galactosidase in yeast: (i) using yeast strains with the
capacity of spontaneous lysis and (ii) using heterologous secretion
signal sequences for extracellular production. In both cases, episomal
plasmids were used for the cloning and expression of recombinant K.
lactis β-galactosidase.
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mutants have been employed to produce and release K. lactis β-
galactosidase into the culture medium (Becerra et al., 1997;
Becerra et al., 2004). In this way, 63 and 83% of total recombinant
β-galactosidase activity could be detected in YPDmedium (yeast
extract peptone dextrose medium) after osmotic shock of the
yeast cells from each strain, respectively (Becerra et al., 1997).
The maximum extracellular β-galactosidase activity obtained
corresponded to 63% of release (Table 1). In this case, plasmid
stability at the end of the culture was about 70%.
(ii) Different recombinant yeast strains able to secrete K. lactis
β-galactosidase into the culture medium have been constructed.
The secretion signal of the K. lactis killer toxinwas used to secrete
K. lactis β-galactosidase in a K. lactis strain mutated in the lac4
gene (Becerra et al., 2001b; Rodríguez et al., 2006). That same
signal sequence and the Saccharomyces α-factor have both been
used to secrete K. lactis β-galactosidase in different S. cerevisiae
strains (Becerra et al., 2001a; Becerra et al., 2001b; Becerra et al.,
2002;Becerra et al., 2004).However, in all theseworksonlypartial
secretion of recombinant β-galactosidase was achieved in the
culture medium. Nevertheless, the constructed strains were able
to grow on lactose as sole carbon source. Different constructions
and culture conditions were experimented to improve
heterologous secretion of K. lactis β-galactosidase. S. cerevisiae
super-secreting mutants, together with the secretion signal of
the K. lactis killer toxin, were used with that purpose but the
maximum recombinant β-galactosidase activity detected in
the culture medium corresponded only to 0.83% of secretion
(Becerra et al., 2001a; Table 1). Although recombinant strains
have grownwell in YPLmedium (yeast extract peptone lactose
medium), theβ-galactosidase activity and plasmid stabilitywere
considerably lower in thismedium than in YPDmedium (plasmid
stability of the best secreting strain: 75% in YPD (120 h) and 43%
in YPL (168 h)). An experimental factorial designwas implemen-
ted to increase the secretion of heterologous β-galactosidase in a
S. cerevisiae strain, using the α-factor signal sequence (Becerra et
al., 2001b; Becerra et al., 2002). Cheese whey permeate, YPD and
YPHSM (YPD medium plus glycerol and calcium chloride) media
were used and the best results were obtained with YPD medium
followed by YPHSM medium (Becerra et al., 2001b). The
extracellular enzyme activity obtained in YPHSM medium at the
determined optimal culture conditions (temperature: 23 °C;
aeration: 2 rpm/mL;NaCl: 0%; time: 72 h) led to an8-fold increase
in β-galactosidase secretion (Becerra et al., 2001b; Table 1). The
production of extracellular recombinant β-galactosidase by the
lac4mutated K. lactis strain was conducted in a 2-L bioreactor in
both batch and continuous conditions, using different media
(Becerra et al., 2001b). The higher extracellular recombinant
β-galactosidase activity was obtained in continuous chemo-
stat culture (μ=0.02 h−1) and corresponded to 6.64% of
enzyme secretion (Becerra et al., 2001b). Plasmid stability was
75% under these conditions. Interestingly, the percentage of
secretion by K. lactis was improved by direct mutagenesis of the
N-terminal of the protein (Becerra et al., 2001b). To further
improve secretion of heterologous β-galactosidase in K. lactis two
hybrid proteins between K. lactis and A. niger β-galactosidases
were constructed (Rodríguez et al., 2006). The secretion signal of
theK. lactis killer toxinwas fused to theN-terminal of each hybrid
protein to allow their secretion. A hybrid enzymewith improved
secretion was obtained by replacing the C-terminal ﬁve domains
ofK. lactisβ-galactosidasewith the correspondingﬁve domainsof
A. niger β-galactosidase. Nevertheless, the activity levels of the
hybrid and native β-galactosidases obtained in that work
(Rodríguez et al., 2006)were lower than that obtained previously
for the native enzyme using the same yeast strain and plasmid
(Becerra et al., 2001b).2.2. Recombinant expression of bacterial β-galactosidases
The most commonly known bacterial β-galactosidase is that from
E. coli (encoded by the lacZ gene). This enzyme has similar properties
to that of K. lactis and is also cytosolic, therefore its intracellular
production is also not biotechnologically attractive. Moreover, this
enzyme is not considered suitable for application in the food industry
due to toxicity problems associated with the host coliform. The lacZ
gene has been cloned in different recombinant yeast expression systems
mainly to function as a reporter gene rather than for heterologous
β-galactosidase production (e.g. Casadaban et al., 1983; Guarente, 1983).
Nevertheless, several attempts were initially made to produce E. coli
β-galactosidase in a secreted form in S. cerevisiae, using different yeast
secretion signal sequences and fusion partners, although with little
success (e.g. Vanoni et al., 1989; Venturini et al., 1997). Efﬁcient secretion
was achieved in this yeast using the signal sequence of GgPI (the major
yeast glycosylphosphatidylinositol-containing protein) (Pignatelli et al.,
1998). In addition, E. coli β-galactosidase was released in recombinant S.
cerevisiae strains using spontaneous lysis strategies or the chemical
permeabilization of the cells (Compagno et al., 1993; Porro et al., 1992).
Several other bacterial β-galactosidases have been cloned and
expressed in different expression systems and host organisms,
especially in recent years (summarized in Table 2). It is worth noting
the increasing interest in the heterologous expression of bacterial
β-galactosidaseswithnovel optimal properties. Recent examples are the
β-galactosidases from thermophilic Caldicellulosiruptor saccharolyticus
(Park and Oh, 2010a), thermoacidophilic Alicyclobacillus acidocaldarius
(Di Lauro et al., 2008; Yuan et al., 2008), hyperthermophilic Thermotoga
maritima (Li et al., 2009a) and cold-adapted Alkalilactibacillus ikkense
(Schmidt and Stougaard, 2010), among many others. Thermostable
β-galactosidases have been attracting much attention owing to their
many advantages for industrial use, including high reaction velocities,
reduced risk of contamination, long half-lives, low product inhibition,
high solubility of substrates and high yields (Chen et al., 2009; Park and
Oh, 2010a). In addition, these new enzymesmay be used during product
processing, such as pasteurization (thermophilic ones) or refrigeration
(cold-adaptedones). Bacterialβ-galactosidases are either intracellular or
expressed at low-levels and for these reasons their heterologous
expression is highly desirable. However, in most of the reports found
in the literature E. coli is used as expression host and themain goal is the
cloning and characterization of the recombinant β-galactosidases
(intracellularly produced) (Table 2). Nevertheless, higher yields of
pure and functional enzyme than that obtained from the natural sources
are frequently reported, especially when fusion partners are used for
puriﬁcation, as hereafter exempliﬁed. The thermostable β-galactosidase
from Thermus sp. strain T2was overexpressed and puriﬁed in E. coli as a
His(six-histidine)-tag fusion protein (Pessela et al., 2003; Table 2).
Almost 3 orders of magnitude of more enzyme activity was obtained
than that produced by the Thermus strain. To improve the recombinant
enzyme puriﬁcation a selective one-point adsorption was achieved by
designing tailor-made low-activated Co-IDA or Ni-IDA supports, which
resulted in more than 90% of recovery of stable enzyme. The fusion tag
did not affect the activation, kinetics parameters and stability of the
recombinant β-galactosidase. Interestingly, recombinant fusion and
non-fusion β-galactosidases presented very close Km values at pH 6.5
and 70 °C, but the fusion enzyme showed a signiﬁcant activity at pH 4.0,
while the native was inactive at this pH. Another thermostable
β-galactosidase (from A. acidocaldarius) was cloned and expressed in
E. coli as a fusion protein with the Schistosoma japonicum glutathione
S-transferase (GST) gene. About 10 mg of pure recombinant protein,
optimally active and stable a 65 °C, was obtained from 1 L of E. coli
culture, whereas 20 L of A. acidocaldarius culture was needed to obtain
5 mg of pure native enzyme (Di Lauro et al., 2008; Table 2). After
removal of the GST portion, the recombinant enzyme showed a speciﬁc
activity 1.5-fold higher than that of the native enzyme, probably due to
its higher purity.
Table 2
Summary of recent reports on the heterologous expression and puriﬁcation of bacterial β-galactosidases in other hosts.
Source of the enzyme Expression host Culture volume and β-galactosidase puriﬁcation yield References
Alicyclobacillus acidocaldariusa Escherichia coli 1 L: 10 mg; 8680 U Di Lauro et al., 2008
Pichia pastoris 4 L: 1.8 mg; 454 U Yuan et al., 2008
Alkalilactibacillus ikkenseb E. coli 200 mL: 2.5 mg; 21 U Schmidt and Stougaard, 2010
Antarctic Arthrobacter sp. 32cb E. coli 1 L: 27 mg; 4209 U Hildebrandt et al., 2009
P. pastoris 1 L: 137 mg; 21,194 U
Bacillus stearothermophilusa B. subtilis n.r.: 209 mg; 26,200 U Chen et al., 2008
Biﬁdobacterium infantisa E. coli n.r.: 6.5 mg; 3697 U Hung and Lee, 2002
Caldicellulosiruptor saccharolyticusa E. coli n.r.: 3.2 mg; 678 U Park and Oh, 2010ac
Enterobacter cloacae E. coli 2 L: puriﬁcation data n.r. Lu et al., 2009c
Lactobacillus acidophilusa E. coli n.r.: 7.34 mg; 317 U Pan et al., 2010
L. acidophilus, L. plantarum, L. reuteri, L. sakei L. plantarum 1 L: 245 U/mg (L. reuteri enzyme in L. plantarum) Halbmayr et al., 2008
L. sakei
Lactococcus lactis 1170–14,000 U/L of culture (puriﬁcation not performed) Maischberger et al., 2010
Lactobacillus delbrueckii subsp. bulgaricus E. coli Puriﬁcation data n.r. Rhimi et al., 2009
L. plantarum L. plantarum 50 mL: 1.7 mg; 265 U Iqbal et al., 2010
L. reuteri E. coli 1 L: 461 mg; 83,000 U Nguyen et al., 2007c
Paenibacillus thiaminolyticus E. coli 1 L: puriﬁcation data n.r. Benešová et al., 2010c
Pseudoalteromonasb E. coli 1 L: 13.8 mg; 1490 U Cieśliński et al., 2005
Pyrococcus woeseia E. coli 1 L: 28 mg; 151,200 U Dąbrowski et al., 2000c
Rhizobium meliloti E. coli 1 L: 4.86 mg; 269 U Leahy et al., 2001
Streptococcus mitis E. coli 2 L: 8.2 mg; 24,350 U Campuzano et al., 2009c
Thermotoga maritimaa E. coli 500 mL: 7.6 mg; 530 U Kim et al., 2004c
100 mL: 40.4 mg; 873 U Li et al., 2009ac
Thermus sp.a E. coli 150 mL: puriﬁcation data n.r. Kang et al., 2005c
1 L: 900,000–958,000 U/mg Pessela et al., 2003c
n.r. — not reported.
a Thermophilic enzymes.
b Cold-adapted enzymes.
c His-tagged recombinant enzymes.
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Bacillus subtilis (Chen et al., 2008; Xia et al., 2010). The thermostable
β-galactosidase from Bacillus stearothermophilus was expressed in B.
subtilis to overcome the lower enzymatic half-life at 60 °C (just 0.5 h)
presented by the homologous recombinant enzyme previously
expressed in E. coli (Chen et al., 2008). Thermostable recombinant β-
galactosidase was successfully expressed in B. subtilis and the speciﬁc
enzymatic activity was more than 45 times of that obtained from B.
stearothermophilus (Hirata et al., 1986). A two-step puriﬁcation proce-
dure, consistingonanionexchangeplus gelﬁltration,wasused to recover
the recombinant enzyme from the cell-free protein extracts (Chen et al.,
2008; Table 2). It is worth noting that a recombinant bacterial
β-galactosidase (from Geobacillus stearothermophilus) has been recently
expressed in a secreted form in B. subtilis when it was fused to a twin-
arginine signal peptide of B. subtilis phosphodiesterase (Xia et al., 2010).
Lactobacillus species were employed aiming an efﬁcient food-grade
overproduction of four Lactobacillus β-galactosidases (Halbmayr et al.,
2008). Halbmayr et al. could inducibly overexpress and purify
Lactobacillus β-galactosidases in Lactobacillus plantarum and Lactoba-
cillus sakei, using a bacteriocin(sakacin P)-based expression system
(Table 2). The highest expression level was obtained for the recombi-
nant Lactobacillus reuteri β-galactosidase expressed in L. plantarum.
Cultivation in a 1-L bioreactor yielded approximately 23,000 U of
β-galactosidase activity, which was considerably higher (9-folds) than
the maximal yield reported for the wild-type L. reuteri strain. The
recombinant enzymewaspuriﬁed from thecell-free protein extracts in a
single puriﬁcation step using afﬁnity chromatography on p-aminoben-
zyl-1-thio-β-D-galactopyranoside agarose, which was clearly more
efﬁcient than the three-step puriﬁcation protocol described for the
puriﬁcation of the native enzyme. Properties of the puriﬁed recombinant
β-galactosidase were found to be essentially the same as those of the
native enzyme or the recombinant enzyme produced in E. coli. However,
in that study the selective pressure of the cultures was still based on
antibiotic resistance (erythromycin). To improve the food-grade
production of Lactobacillus β-galactosidases, Maischberger et al. (2010)
overexpressed the same enzymes in Lactococcus lactis using the food-grade nisin-controlled expression system NICE and plasmid selection
based on the ability to growon lactose (Table 2). In thisway, 8400 U/L of
fermentation medium of recombinant L. reuteri β-galactosidase activity
was obtained, which was also considerably higher than that obtained
with the original host (2500 U/L). This food-grade recombinant
expression system is more advantageous than the previous one as it
yielded more recombinant β-galactosidase under the same cultivation
conditions (50 mLﬂask cultures), using a food-grade inducer (nisin) and
without the need of antibiotics for selective pressure. The puriﬁcation
and the characterization of the recombinant enzymewere not reported;
nevertheless, the application of the GRAS host together with the food-
grade expression system was suggested for the production of lactose-
free products or novel prebiotic GOS (Maischberger et al., 2010).
The methylotrophic yeast Pichia pastoris was employed to produce
two bacterialβ-galactosidases aiming at their industrial application. The
thermostable β-galactosidase from A. acidocaldarius (Yuan et al., 2008)
and thecold-adaptedβ-galactosidase fromAntarcticArthrobacter sp. 32c
(Hildebrandt et al., 2009)were successfully expressed in a secreted form
in this heterologous host, making use of the Saccharomyces α-factor
signal sequence. Themajor advantage of secreting recombinant proteins
in P. pastoris is that this yeast secretes very low levels of native proteins,
which facilitates the puriﬁcation of the recombinant protein. The
amount of recombinant A. acidocaldarius thermostable β-galactosidase
secreted in P. pastoris shake-ﬂask cultures (90 mg/L) was higher than
that expressed naturally (Yuan et al., 2008). Furthermore, this
recombinant overexpression system was more efﬁcient than the E. coli
expression system (10–70 mg/L; Di Lauro et al., 2008). Nevertheless, the
three-step puriﬁcation procedure adopted for the puriﬁcation of the
recombinant enzyme from the P. pastoris supernatants allowedonly 6.7%
of enzyme recovery, which was considerably lower than that obtained
from E. coli (Table 2). Note that the genes encoding A. acidocaldarius
β-galactosidase cloned in each recombinant expression system were
different but shared 97% of identity (E. coli: lacB gene; P. pastoris: Bgly
gene). The pH and temperature optima of the recombinant enzyme
produced in P. pastoriswere similar to that of thenative enzyme (5.8 and
70 °C, respectively).
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amounts of pure recombinant Antarctic Arthrobacter β-galactosidase
were obtained than using the E. coli expression system (Hildebrandt
et al., 2009; Table 2). Afﬁnity chromatography on p-aminobenzyl-1-
thio-β-D-galactopyranoside agarose was used for the puriﬁcation of
the recombinant enzymes. The authors considered the P. pastoris
system a high efﬁcient and cheap way to produce this cold-adapted
enzymeextracellularly (cost of 1 mgof puriﬁedenzymewas estimated at
0.03€). Nevertheless, its optimal activity was determined at 50 °C (pH
6.5) and only 15% to 20% of maximum activity was detected in the
0–10 °C temperature range. Similarly, the cold-adapted Pseudoalteromo-
nas β-galactosidase expressed and puriﬁed from E. coli cells also retained
just 20% of maximum activity at 10 °C (Cieśliński et al., 2005). On the
other hand, the cold-adapted A. ikkense β-galactosidase produced and
puriﬁed from the same bacterial expression system was much more
active and stable at low temperatures. This recombinant enzyme
maintained more than 60% of its activity at 0 °C and was stable for
more than 100 h at temperatures of 10 °C or below, without the use of
stabilizing agents (Schmidt and Stougaard, 2010).
2.3. Applications of recombinant β-galactosidases
The β-galactosidase enzymes produced by means of recombinant
DNA technology present several advantages in terms of the
production and puriﬁcation processes. Moreover, recombinant en-
zymes with improved properties may be obtained. Nevertheless, the
evaluation of their applications has only been reported for some of
them.
2.3.1. Milk lactose hydrolysis
The traditional use of β-galactosidase in dairy industry has been
the hydrolysis of lactose in milk (Fig. 1). Curiously, most of the reports
on the use of recombinant β-galactosidases are related with this
application.
The Pseudoalteromonas cold-adapted β-galactosidase enzyme,
produced and puriﬁed from E. coli cells (Cieśliński et al., 2005;
Table 2), was applied in the hydrolysis of lactose in a milk assay where
90% of milk lactose was hydrolyzed for 6 h at 30 °C. The advantage of
this recombinant enzyme is that it can be used at lower temperatures
hydrolyzing 90% of milk lactose in 28 h at 15 °C. Recombinant cold-
adapted L. acidophilus β-galactosidase (Pan et al., 2010; Table 2),
produced and puriﬁed also from the E. coli expression system,
hydrolyzed 73% of lactose in milk in 30 h at 10 °C (Pan et al., 2010).
A couple of thermophilic β-galactosidase enzymes encoding genes
have also been cloned in different expression hosts and tested for the
hydrolysis of milk lactose. The use of thermophilic β-galactosidases
may prevent microbial contamination to some extent in milk
processing, functioning under conditions that normally denature
mesophilic enzymes. As a consequence, its expression in hosts that
enable production on an industrial scale has become of interest. The
Pyrococcus woesei thermostable β-galactosidase, produced and puri-
ﬁed from E. coli cells (Dąbrowski et al., 2000; Table 2), was
characterized and displayed high activity and thermostability. For
testing its application on lactose hydrolysis, the recombinant enzyme
was immobilized in chitin and packed in a jacketed column. A study of
continuous operation of the column was made at pH 5.4 in 0.01 M
phosphate citrate buffer with 5% lactose at 75 °C and a ﬂow rate of
80 mL/h. Unexpectedly, the immobilized enzyme exhibited a rela-
tively short half-life value (31 h). Another more up to date example of
recombinant thermostable β-galactosidase application in milk lactose
hydrolysis is reported in the study conducted by Yuan et al. (2008)
with the β-galactosidase from Alicyclobacillus acidocaldarius produced
from the Pichia expression system (Table 2). Approximately 48% of
lactose in milk was hydrolyzed following treatment with the
recombinant enzyme over 60 min at 65 °C, while the hydrolysis rate
was signiﬁcantly higher in a lactose solution under the sameconditions. The authors attributed the discrepancy between lactose
hydrolysis in milk and lactose solution to inhibitory effects of other
components in milk. Another recent example, is the very interesting
thermostable recombinant β-galactosidase enzyme from B. stear-
othermophilus (Chen et al., 2008; Table 2) used for lactose hydrolysis
in milk (Chen et al., 2009). The enzyme characterization revealed that
the recombinant β-galactosidase was active at high temperatures up
to 75 °C and displayed elevated thermostability as well. The enhanced
stability properties, combined with its neutral pH activity and
favorable temperature activity optimum, suggest that this enzyme is
an ideal candidate for the hydrolysis of lactose in milk, and would be
suitable for application in low-lactose milk production during milk
pasteurization (Chen et al., 2008). In fact, the recombinant enzyme (at
a concentration of 2 U/mL) hydrolyzed 100% milk lactose at 65 °C for
100 min (Chen et al., 2008). Moreover, the recombinant thermostable
β-galactosidase possessed a high level of transgalactosylation activity
in parallel with the hydrolysis of lactose in milk. Oligosaccharides are
no longer considered as undesired products as in early times (see
Shuklaa andWierzbickib, 1975) but its presence in low-lactose milk is
nowadays regarded as a valuable trait. Indeed, GOS produced via the
transgalactosylation activity of β-galactosidase are utilized as growth-
promoting substrates of biﬁdobacteria in the human intestine (Park
and Oh, 2010b). The recombinant thermostable β-galactosidase from
B. stearothermophilus was immobilized onto chitosan using Tris
(hydroxymethyl)phosphine (THP) and glutaraldehyde, and a packed
bed reactor was utilized to hydrolyze lactose in milk (Chen et al.,
2009). The THP-immobilized enzyme displayed better enzyme activity,
reusability, thermostability, and storage stability compared with free
and glutaraldehyde-immobilized enzymes. More than 80% of lactose
hydrolysis was achieved after 2 h of operation at 70 °C in a packed-bed
reactor with THP-immobilized β-galactosidase (Chen et al., 2009).
The recombinant acidotolerant β-galactosidase from Lactobacillus
delbrueckii subsp. bulgaricus ATCC 11842, produced from the E. coli
expression system,has beenexplored for lactosehydrolysis (Rhimiet al.,
2009; Table 2). Biochemical characterization of the puriﬁed protein
revealed optimal activity in a wide temperature range (35 to 50 °C) and
at pH values comprised between 5.0 and 5.5. Interestingly, primary
structure alignment suggested that only acidotolerant enzymes includ-
ing that of L. bulgaricus have glutamic acid at position 491.Making use of
the E. coli recombinant systemand site-directedmutagenesis amodiﬁed
version of the recombinant enzymewas produced: the glutamic acid at
position 491 was replaced by alanine (E491A). The biochemical
characterization revealed that the E491A mutation did not affect the
kinetic parameters and temperature proﬁle of the protein but the pH
optima proﬁle was undoubtedly shifted from 5.0–5.5 for the wild-type
enzyme to 6.5–7.0 for the modiﬁed enzyme. When comparing lactose
hydrolysis rates both in milk and whey, the original version was more
efﬁcient forwhey hydrolysis (88% bioconversion at 42 °C after 10 hwith
1 mg/mL β-galactosidase against 60% for the mutated version in the
same conditions) while the mutated version was more efﬁcient in milk
lactose hydrolysis (89% bioconversion at 42 °C after 10 h with 1 mg/mL
β-galactosidase against 80% for the original version).
2.3.2. Whey bioremediation
Several alternatives have been proposed for the treatment and
valorization of cheese whey (reviewed in Guimarães et al., 2010) with
some of them involving the use of the β-galactosidase enzyme (Fig. 1).
However, there are very few reports on theuse of recombinant enzymes
concerning this application. One is the above mentioned acidotolerant
β-galactosidase from L. bulgaricus produced and puriﬁed from E. coli
cells. Typically, fungal β-galactosidases have acidic pH-optima and thus
they are most effective for the hydrolysis of lactose present in acidic
products such aswhey. The industrially relevantβ-galactosidase fromA.
nigerhasbeenproduced inﬂocculentS. cerevisiae cells (seeSection2.1.1)
and applied in whey hydrolysis. In a preliminary assay, the produced
recombinant enzyme was ultraﬁltrated and applied directly for whey
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solution) achieving 90% lactose bioconversion in 20 h at 30 °C
(Domingues et al., 2003). This recombinant system could be of interest
for the dairy industry as the recombinant β-galactosidase was secreted
from ﬂocculent S. cerevisiae cells at the same time as ethanol was
produced while using whey permeate as substrate (Domingues et al.,
2002). Moreover, with a simple ultraﬁltration step the produced
enzyme could be easily applied for lactose bioconversion. Nevertheless,
further research on lactose hydrolysis by this enzyme is needed.
2.3.3. Biosensors and fusion proteins
Recombinant β-galactosidase (normally, E. coli β-galactosidase) has
been extensively used as a fusion protein in different ﬁelds due to its easy
detection (Caubín et al., 2001; Huang et al., 2009). One of the most
relevant applications is in biosensors. The expression and production of
recombinant β-galactosidases have been determinants for the progress
of this area. Several works can be found in literature concerning the use
of recombinant β-galactosidases in biosensors construction and func-
tionalization. One example is the use of a chimera protein made by the
fusion of β-galactosidase from E. coli and the choline-binding domain of
the (acetylmuramoyl)-L-alanine amidase from Streptococcus pneumo-
niae in the development of a speciﬁc immobilizationmethod of proteins
onto a gold electrode (Madoz et al., 1997). Also worth of noting is the
application of recombinant fusion β-galactosidases in the development of
allosteric biosensors. These speciﬁc biosensors allow detection of
antibodies against different viruses by accommodating peptide sequences
from surface viral proteins, acting as antibody receptors, into permissive
sites of allosterically responsive recombinantβ-galactosidases. Among the
advantages of such biosensors as diagnostic tools is the homogeneous
nature of the assay, the short time required for the enzymatic reaction and
antibody detection, and the potential for handling large number of
samples and for automatic processing, as shown for human immunode-
ﬁciency virus (Ferraz et al., 2006; Ferraz et al., 2008). More recently,
allosteric biosensors for detection of the animal foot-and-mouth disease
virus (FMDV) have been developed, allowing the differentiation between
sera FMDV-infected animals and those of naïve and conventionally
vaccinated ones (Sánchez-Aparicio et al., 2009).
As new enzymes are discovered and characterized by recombi-
nant DNA technology, new biosensors are also described in
literature. One recent example is a β-galactosidase having a modular
structurewith a choline-binding domain that has been identiﬁed for the
ﬁrst time in Streptococcus mitis (Campuzano et al., 2009; Table 2). The
recombinant enzyme, produced from the E. coli expression system,
presented negligible product inhibition by higher concentrations of
glucose, weak inhibition by galactose in comparison with other β-
galactosidases, high substrate speciﬁcity towards lactose and superior
stability at room temperature. The authors state that they have under
development for application in the dairy industry a promising integrated
amperometric lactose biosensor which contains the recombinant S. mitis
β-galactosidase, glucose oxidase, peroxidase, and tetrathiafulvalene
coimmobilized by cross-linking with glutaraldehyde in a gold disk
electrode modiﬁed with a 3-mercaptopropionic acid self-assembled
monolayer (Campuzano et al., 2009).
2.3.4. Other applications
Besides their hydrolytic activity on lactose, β-galactosidase enzymes
may also possess transgalactosylation activity which expands their
potential applications (Fig. 1). The transferase activity enables not only
the synthesis of GOS, increasingly documented as useful nutritional
instruments for themodulation of colonic microﬂora towards a healthy
balance, but can also be used to attach galactose to other chemicals and
consequently have imminent applications in the production of
biological active compounds (Panesar et al., 2006). Therefore, the
search for newβ-galactosidase enzymeswith transferase activity and its
expressionandproduction fromrecombinanthosts in order tobe able to
characterize their GOS production has been progressively reported inliterature. Recombinant thermostable T. maritima β-galactosidase,
produced and puriﬁed from E. coli cells (Kim et al., 2004; Table 2), was
used for GOS production (Ji et al., 2005). More recently, the character-
ization of the GOS produced by a β-galactosidase from L. plantarum has
been reported (Iqbal et al., 2010; Table 2). The enzyme was efﬁciently
overproduced in the homologous expression Lactobacillus system,
presented a high transgalactosylation activity and was used for the
synthesis of prebiotic GOS. Another example of newly isolated
β-galactosidaseswith transferase activity is the one from Enterobacter
cloacae B5, overexpressed from the E. coli expression system (Lu et al.,
2009; Lu et al., 2010; Table 2). This recombinant enzyme was
employed to synthesize novel galactose containing chemicals using
galactosyl mannitol, galactosyl sorbose and galactosyl salicin as
acceptors in the presence of o-nitrophenyl-β-D-galactopyranoside
as donor (Lu et al., 2010). Some of the β-galactosidase enzymes are
recognized to display not only β-D-galactosidase activity, but also the
β-D-fucosidase, β-D-glucosidase, orα-L-arabinosidase activity (Chang
et al., 2009). Interestingly, Benešová et al. (2010) have identiﬁed a
β-galactosidasewithβ-D-fucosidase activity from a genomic library of
the bacterial strain Paenibacillus thiaminolyticus (Table 2). According
to the reported results, this enzyme seems to be a promising tool for the
synthesis of different types of β-D-fucosylated molecules with huge
potential in biotechnology and pharmaceutical industry (Benešová et al.,
2010).
3. Concluding remarks and future trends
In recent times, it is patent (meaning obvious) a raising trend for the
isolation and characterization of novel β-galactosidase enzymes. The
use of recombinant expression systems has been vital not only for this
progress but also for large-scale production of the most interesting
identiﬁed enzymes. Two trends can be distinguished: one related with
the traditional hydrolytic activity of β-galactosidase where novel cold-
active and also thermophilic enzymes have been described, and the
other relatedwith the characterization of innovative proteinswithother
activities besides the hydrolytic one. Even though β-galactosidase
hydrolytic activity has been traditionally used in the dairy industry for
obtaining lactose-free products there is still place for new develop-
ments. For instance, several cold-active β-galactosidases, which can be
used to hydrolyze lactose to glucose and galactose from refrigerated
milk at low temperature, have been identiﬁed and characterized. One
recent interesting example is β-galactosidase from the psychrotolerant
yeast Guehomyces pullulans 17-1 (Song et al., 2010). This yeast was
isolated from sea sediment in Antarctica and produces β-galactosidase
extracellularly. From the other side, the use of thermophilic enzymes in
the production of lactose-hydrolyzed products also presents signiﬁcant
advantages when comparing with the traditional process, as above
mentioned (Section 2.2). In the case of low-lactose milk, an important
advantage is that the use of thermophilic enzymes enables lactose
hydrolysis during the pasteurization process. Presumably, the use of
these thermostable β-galactosidases, cold-active or thermophilic, will
be progressively incorporated by the dairy industry. Due to the key role
of GOS in the ﬁeld of functional foods, β-galactosidases with transferase
and other activities will undoubtedly draw most of the researcher's
attention. Since the GOS products currently available on the market
were not designed rationally, there is still need to ﬁnd good microbial
sources ofβ-galactosidasesallowinghigh transgalactosylation activities,
and to characterize the individual components of the GOS mixtures,
obtained with these biocatalysts (Iqbal et al., 2010). Actually, this is a
very active research ﬁeld which will most probably continue to grow. In
this context, recombinant production systems are crucial as themicrobial
sources of these β-galactosidase enzymes are usually not GRAS andmay
present tedious growth and productivities. Besides that, recombinant
systems are also essential for generating improved versions of the
enzymes. For instance, when changing arginine to triptophan at position
109 (R109W) on the β-galactosidase from G. stearothermophilus, the
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increased by approximately 12- and 17-folds, respectively (Placier et al.,
2009). As in the transgalactosylation reaction glucose inhibition is a
concern, a modiﬁed β-galactosidase at glucose- or galactose-binding site
that shows reduced inhibition by glucose or galactose is highly desirable
(Park and Oh, 2010b).
At present, it is worth noting that the synthetic capabilities of
β-galactosidases are continuously expanding (Lu et al., 2010). Some
β-galactosidases display broad substrate speciﬁcity together with the
ability to transfer diversemonsaccharidic residues to different sacchari-
dic or nonsaccharidic acceptors (Benešová et al., 2010). Recent reports
show the effective enzymatic synthesis by β-galactosidase of different
types of β-D-fucosylatedmolecules (Benešová et al., 2010), lactosucrose
(Li et al., 2009b) and lactulose (Kim et al., 2006; Lee et al., 2004). In
addition, more acceptors such asmannitol, sorbose, salicin, sorbitol and
trehalose have also been found to be glycosylated by these enzymes to
form novel chemicals (Kim et al., 2007; Klewicki, 2007a,b; Lu et al.,
2010). Undoubtedly, the trend is that β-galactosidase enzymes will
develop into promising synthetic tools.
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